SCHEMBL18800598

SCHEMBL18800598

N=C(N)c1c(N)cncc1-c1ccc2ccccc2c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.51
▸ DHFR P00374 1/20 0.46
▸ CCNC P24863 4/20 0.45
▸ CDK8 P49336 4/20 0.45
▸ ADORA2A P29274 1/20 0.43
▸ ADORA1 P30542 1/20 0.43
▸ F2 P00734 1/20 0.42
▸ PLG P00747 1/20 0.42
▸ PLAU P00749 1/20 0.42
▸ KLKB1 P03952 1/20 0.42
▸ KLK1 P06870 1/20 0.42
▸ PRSS1 P07477 1/20 0.42
▸ CYP11B1 P15538 5/20 0.41
▸ CYP11B2 P19099 5/20 0.41
▸ CYP1A2 P05177 3/20 0.41
▸ CYP3A4 P08684 2/20 0.41
▸ CYP2D6 P10635 2/20 0.41
▸ CYP2C9 P11712 2/20 0.41
▸ CYP2C19 P33261 2/20 0.41
▸ CYP2B6 P20813 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18800614 0.76 ERBB2 (0.42) CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL18800716 0.76 PRKCQ (0.37) ADORA1F2PLGPRSS1CYP1A2
SCHEMBL18800557 0.75 PRSS1 (0.45) PRSS1CYP11B1CYP11B2CYP1A2CYP3A4
SCHEMBL18800739 0.73 MEN1 (0.39) F2PLAUPRSS1
SCHEMBL18800873 0.72 SCN5A (0.37) CCNCCDK8CYP11B1CYP11B2
SCHEMBL18800606 0.72 NQO2 (0.43) F2PLAUPRSS1CYP11B1CYP11B2
SCHEMBL18800626 0.72 SMN1; SMN2 (0.48) KDM4EF2PRSS1CYP11B1CYP11B2
SCHEMBL18800610 0.70 BTK (0.43) F2PRSS1CYP11B1CYP11B2CYP3A4
SCHEMBL18800479 0.69 BTK (0.54) PRKCZALDH1A1
SCHEMBL29419521 0.68 DHFR (0.56) KDM4EDHFRCCNCCDK8ADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2789615-B1 Azaindazoles as Btk kinase modulators and use thereof BRISTOL MYERS SQUIBB CO (US) 2017-05-03 — — EP disclosed
Send feedback